Literature DB >> 14619985

Towards understanding molecular mechanisms of action of homeopathic drugs: an overview.

Anisur Rahman Khuda-Bukhsh1.   

Abstract

The homeopathic mode of treatment often encourages use of drugs at such ultra-low doses and high dilutions that even the physical existence of a single molecule of the original drug substance becomes theoretically impossible. But homeopathy has sustained for over two hundred years despite periodical challenges thrown by scientists and non-believers regarding its scientificity. There has been a spurt of research activities on homeopathy in recent years, at clinical, physical, chemical, biological and medical levels with acceptable scientific norms and approach. While clinical effects of some homeopathic drugs could be convincingly shown, one of the greatest objections to this science lies in its inability to explain the mechanism of action of the microdoses based on scientific experimentations and proofs. Though many aspects of the mechanism of action still remain unclear, serious efforts have now been made to understand the molecular mechanism(s) of biological responses to the potentized form of homeopathic drugs. In this communication, an overview of some interesting scientific works on homeopathy has been presented with due emphasis on the state of information presently available on several aspects of the molecular mechanism of action of the potentized homeopathic drugs.

Mesh:

Year:  2003        PMID: 14619985     DOI: 10.1023/a:1026048907739

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

1.  Inhibition of human basophil degranulation by successive histamine dilutions: results of a European multi-centre trial.

Authors:  P Belon; J Cumps; M Ennis; P F Mannaioni; J Sainte-Laudy; M Roberfroid; F A Wiegant
Journal:  Inflamm Res       Date:  1999-04       Impact factor: 4.575

2.  A controlled evaluation of a homoeopathic preparation in the treatment of influenza-like syndromes.

Authors:  J P Ferley; D Zmirou; D D'Adhemar; F Balducci
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

3.  A study of the effect of decimal and centesimal dilutions of arsenic on the retention and mobilization of arsenic in the rat.

Authors:  J C Cazin; M Cazin; J L Gaborit; A Chaoui; J Boiron; P Belon; Y Cherruault; C Papapanayotou
Journal:  Hum Toxicol       Date:  1987-07

4.  Efficacy of a potentized homoeopathic drug (Arsenicum Album-30) in reducing genotoxic effects produced by arsenic trioxide in mice: II. Comparative efficacy of an antibiotic, actinomycin D alone and in combination with either of two microdoses.

Authors:  S Datta; P Mallick; A R Bukhsh
Journal:  Complement Ther Med       Date:  1999-09       Impact factor: 2.446

5.  Critical review and meta-analysis of serial agitated dilutions in experimental toxicology.

Authors:  K Linde; W B Jonas; D Melchart; F Worku; H Wagner; F Eitel
Journal:  Hum Exp Toxicol       Date:  1994-07       Impact factor: 2.903

6.  Efficacy of a potentized homoeopathic drug (Arsenicum Album-30) in reducing genotoxic effects produced by arsenic trioxide in mice: comparative studies of pre-, post- and combined pre- and post-oral administration and comparative efficacy of two microdoses.

Authors:  S Datta; P Mallick; A R Bukhsh
Journal:  Complement Ther Med       Date:  1999-06       Impact factor: 2.446

7.  Effects of acetyl salicylic acid therapy on an experimental thrombosis induced by laser beam.

Authors:  O Aguejouf; E Malfatti; P Belon; C Doutremepuich
Journal:  Thromb Res       Date:  2000-09-15       Impact factor: 3.944

8.  Thromboembolic complications several days after a single-dose administration of aspirin.

Authors:  O Aguejouf; E Belougne-Malfatti; F Doutremepuich; P Belon; C Doutremepuich
Journal:  Thromb Res       Date:  1998-02-01       Impact factor: 3.944

9.  Human basophil degranulation triggered by very dilute antiserum against IgE.

Authors:  E Davenas; F Beauvais; J Amara; M Oberbaum; B Robinzon; A Miadonna; A Tedeschi; B Pomeranz; P Fortner; P Belon
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

10.  Clinical trials of homoeopathy.

Authors:  J Kleijnen; P Knipschild; G ter Riet
Journal:  BMJ       Date:  1991-02-09
View more
  22 in total

1.  Protective potentials of a potentized homeopathic drug, Lycopodium-30, in ameliorating azo dye induced hepatocarcinogenesis in mice.

Authors:  Surajit Pathak; Jayanta Kumar Das; Surjyo Jyoti Biswas; Anisur Rahman Khuda-Bukhsh
Journal:  Mol Cell Biochem       Date:  2006-03-15       Impact factor: 3.396

2.  Patient satisfaction and side effects in primary care: an observational study comparing homeopathy and conventional medicine.

Authors:  Florica Marian; Kerstin Joost; Krishan D Saini; Klaus von Ammon; André Thurneysen; André Busato
Journal:  BMC Complement Altern Med       Date:  2008-09-18       Impact factor: 3.659

3.  Can homeopathic arsenic remedy combat arsenic poisoning in humans exposed to groundwater arsenic contamination?: a preliminary report on first human trial.

Authors:  Anisur Rahman Khuda-Bukhsh; Surajit Pathak; Bibhas Guha; Susanta Roy Karmakar; Jayanta Kumar Das; Pathikrit Banerjee; Surjyo Jyoti Biswas; Partha Mukherjee; Nandini Bhattacharjee; Sandipan Chaki Choudhury; Antara Banerjee; Suman Bhadra; Palash Mallick; Jayati Chakrabarti; Biswapati Mandal
Journal:  Evid Based Complement Alternat Med       Date:  2005-10-19       Impact factor: 2.629

4.  Immunology and homeopathy. 1. Historical background.

Authors:  Paolo Bellavite; Anita Conforti; Valeria Piasere; Riccardo Ortolani
Journal:  Evid Based Complement Alternat Med       Date:  2005-12       Impact factor: 2.629

5.  Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200.

Authors:  Nandini Bhattacharjee; Surajit Pathak; Anisur Rahman Khuda-Bukhsh
Journal:  Evid Based Complement Alternat Med       Date:  2007-06-19       Impact factor: 2.629

6.  Stimulation of lymphocyte anti-melanoma activity by co-cultured macrophages activated by complex homeopathic medication.

Authors:  Fernando S F Guimarães; Ana P R Abud; Simone M Oliveira; Carolina C Oliveira; Beatriz César; Lucas F Andrade; Lucélia Donatti; Juarez Gabardo; Edvaldo S Trindade; Dorly F Buchi
Journal:  BMC Cancer       Date:  2009-08-22       Impact factor: 4.430

7.  Can homeopathy bring additional benefits to thalassemic patients on hydroxyurea therapy? Encouraging results of a preliminary study.

Authors:  Antara Banerjee; Sudipa Basu Chakrabarty; Susanta Roy Karmakar; Amit Chakrabarty; Surjyo Jyoti Biswas; Saiful Haque; Debarsi Das; Saili Paul; Biswapati Mandal; Boujedaini Naoual; Philippe Belon; Anisur Rahman Khuda-Bukhsh
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-29       Impact factor: 2.629

8.  Modulation of Signal Proteins: A Plausible Mechanism to Explain How a Potentized Drug Secale Cor 30C Diluted beyond Avogadro's Limit Combats Skin Papilloma in Mice.

Authors:  Anisur Rahman Khuda-Bukhsh; Soumya Sundar Bhattacharyya; Saili Paul; Suman Dutta; Naoual Boujedaini; Philippe Belon
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-18       Impact factor: 2.629

9.  Evidences of protective potentials of microdoses of ultra-high diluted arsenic trioxide in mice receiving repeated injections of arsenic trioxide.

Authors:  Pathikrit Banerjee; Soumya Sundar Bhattacharyya; Surajit Pathak; Naoual Boujedaini; Philippe Belon; Anisur Rahman Khuda-Bukhsh
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-14       Impact factor: 2.629

10.  Can administration of potentized homeopathic remedy, Arsenicum album, alter antinuclear antibody (ANA) titer in people living in high-risk arsenic contaminated areas? I. A correlation with certain hematological parameters.

Authors:  Philippe Belon; Pathikrit Banerjee; Sandipan Chaki Choudhury; Antara Banerjee; Surjyo Jyoti Biswas; Susanta Roy Karmakar; Surajit Pathak; Bibhas Guha; Sagar Chatterjee; Nandini Bhattacharjee; Jayanta Kumar Das; Anisur Rahman Khuda-Bukhsh
Journal:  Evid Based Complement Alternat Med       Date:  2006-01-23       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.